71 related articles for article (PubMed ID: 7911462)
1. Secretion of alpha 2-plasmin inhibitor is impaired by amino acid deletion in a small region of the molecule.
Toyota S; Hirosawa S; Aoki N
J Biochem; 1994 Feb; 115(2):293-7. PubMed ID: 7911462
[TBL] [Abstract][Full Text] [Related]
2. Hereditary alpha 2-plasmin inhibitor deficiency caused by a transport-deficient mutation (alpha 2-PI-Okinawa). Deletion of Glu137 by a trinucleotide deletion blocks intracellular transport.
Miura O; Sugahara Y; Aoki N
J Biol Chem; 1989 Oct; 264(30):18213-9. PubMed ID: 2572590
[TBL] [Abstract][Full Text] [Related]
3. Construction and expression of alpha 1-proteinase inhibitor mutants and the effects of these mutations on secretion of the variant inhibitors.
McCracken AA; Kruse KB; Valentine J; Roberts C; Yohannes TZ; Brown JL
J Biol Chem; 1991 Apr; 266(12):7578-82. PubMed ID: 2019587
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence.
Miura O; Hirosawa S; Kato A; Aoki N
J Clin Invest; 1989 May; 83(5):1598-604. PubMed ID: 2496145
[TBL] [Abstract][Full Text] [Related]
5. Expression and characterization of pro alpha 2-plasmin inhibitor.
Sumi Y; Ichikawa Y; Nakamura Y; Miura O; Aoki N
J Biochem; 1989 Oct; 106(4):703-7. PubMed ID: 2606916
[TBL] [Abstract][Full Text] [Related]
6. Different NH2-terminal form with 12 additional residues of alpha 2-plasmin inhibitor from human plasma and culture media of Hep G2 cells.
Koyama T; Koike Y; Toyota S; Miyagi F; Suzuki N; Aoki N
Biochem Biophys Res Commun; 1994 Apr; 200(1):417-22. PubMed ID: 8166714
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of alpha 2 plasmin inhibitor.
Aoki N
Adv Exp Med Biol; 1990; 281():195-200. PubMed ID: 2102612
[TBL] [Abstract][Full Text] [Related]
8. Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin.
Wang H; Yu A; Wiman B; Pap S
Eur J Biochem; 2003 May; 270(9):2023-9. PubMed ID: 12709062
[TBL] [Abstract][Full Text] [Related]
9. Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin).
Holmes WE; Nelles L; Lijnen HR; Collen D
J Biol Chem; 1987 Feb; 262(4):1659-64. PubMed ID: 2433286
[TBL] [Abstract][Full Text] [Related]
10. Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity.
Holmes WE; Lijnen HR; Nelles L; Kluft C; Nieuwenhuis HK; Rijken DC; Collen D
Science; 1987 Oct; 238(4824):209-11. PubMed ID: 2958938
[TBL] [Abstract][Full Text] [Related]
11. Characterization of recombinant human alpha 2-antiplasmin and of mutants obtained by site-directed mutagenesis of the reactive site.
Holmes WE; Lijnen HR; Collen D
Biochemistry; 1987 Aug; 26(16):5133-40. PubMed ID: 2444252
[TBL] [Abstract][Full Text] [Related]
12. The defective secretion of a naturally occurring alpha-1-antichymotrypsin variant with a frameshift mutation.
Tsuda M; Sei Y; Ohkubo T; Yamamura M; Kamiguchi H; Akatsuka A; Tsuda T; Tachikawa H; Yamamoto M; Shinohara Y
Eur J Biochem; 1996 Feb; 235(3):821-7. PubMed ID: 8654434
[TBL] [Abstract][Full Text] [Related]
13. Structure of the carboxyl-terminal half of human alpha 2-plasmin inhibitor deduced from that of cDNA.
Sumi Y; Nakamura Y; Aoki N; Sakai M; Muramatsu M
J Biochem; 1986 Nov; 100(5):1399-402. PubMed ID: 3818581
[TBL] [Abstract][Full Text] [Related]
14. [Molecular basis for hereditary deficiency of alpha 2-plasmin inhibitor].
Aoki N; Miura O
Rinsho Byori; 1990 Jul; Suppl 86():109-15. PubMed ID: 2232232
[No Abstract] [Full Text] [Related]
15. Primary structure of bovine alpha 2-antiplasmin.
Christensen S; Berglund L; Sottrup-Jensen L
FEBS Lett; 1994 May; 343(3):223-8. PubMed ID: 7513654
[TBL] [Abstract][Full Text] [Related]
16. A single thymine nucleotide deletion responsible for congenital deficiency of plasmin inhibitor.
Yoshinaga H; Nakahara M; Koyama T; Shibamiya A; Nakazawa F; Miles LA; Hirosawa S; Aoki N
Thromb Haemost; 2002 Jul; 88(1):144-8. PubMed ID: 12152655
[TBL] [Abstract][Full Text] [Related]
17. Human alpha 2-plasmin inhibitor.
Aoki N; Sumi Y; Miura O; Hirosawa S
Methods Enzymol; 1993; 223():185-97. PubMed ID: 8271952
[No Abstract] [Full Text] [Related]
18. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
Mimuro J; Kimura S; Aoki N
J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360
[TBL] [Abstract][Full Text] [Related]
19. Purification of human alpha 2-antiplasmin with chicken IgY specific to its carboxy-terminal peptide.
Lee SC; Lee KN; Schwartzott DG; Jackson KW; Tae WC; McKee PA
Prep Biochem Biotechnol; 1997 Nov; 27(4):227-37. PubMed ID: 9413556
[TBL] [Abstract][Full Text] [Related]
20. Interaction of plasmin with tranexamic acid and alpha 2 plasmin inhibitor in the plasma and clot.
Takada A; Ito T; Takada Y
Thromb Haemost; 1980 Feb; 43(1):20-3. PubMed ID: 6447383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
